BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4092724)

  • 1. Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.
    Stäubli M; Troendle A; Schmid B; Balmer P; Kohler B; Studer H; Bircher J
    Eur J Clin Pharmacol; 1985; 29(4):417-23. PubMed ID: 4092724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
    Barbieri E; Conti F; Zampieri P; Trevi GP; Zardini P; d'Aranno V; Latini R
    J Am Coll Cardiol; 1986 Jul; 8(1):210-3. PubMed ID: 3711518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
    Stäubli M; Bircher J; Galeazzi RL; Remund H; Studer H
    Eur J Clin Pharmacol; 1983; 24(4):485-94. PubMed ID: 6861863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine kinetic studies during amiodarone treatment.
    Rao RH; McCready VR; Spathis GS
    J Clin Endocrinol Metab; 1986 Mar; 62(3):563-8. PubMed ID: 3944239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy.
    Marchiset D; Bruno R; Djiane P; Cano JP; Benichou M; Serradimigni A
    Biopharm Drug Dispos; 1985; 6(2):209-15. PubMed ID: 4005397
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentration response relationships of amiodarone and desethylamiodarone.
    Connolly SJ; Gupta RN; Hoffert D; Roberts RS
    Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and body distribution of amiodarone in man.
    Plomp TA; van Rossum JM; Robles de Medina EO; van Lier T; Maes RA
    Arzneimittelforschung; 1984; 34(4):513-20. PubMed ID: 6540111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
    Nitsch J; Lüderitz B
    Dtsch Med Wochenschr; 1984 Mar; 109(13):492-5. PubMed ID: 6423357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone pharmacokinetics.
    Holt DW; Tucker GT; Jackson PR; Storey GC
    Am Heart J; 1983 Oct; 106(4 Pt 2):840-7. PubMed ID: 6613830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
    Falik R; Flores BT; Shaw L; Gibson GA; Josephson ME; Marchlinski FE
    Am J Med; 1987 Jun; 82(6):1102-8. PubMed ID: 3605129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
    Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
    Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
    Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
    Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
    Nattel S; Davies M; Quantz M
    Circulation; 1988 Jan; 77(1):200-8. PubMed ID: 2446801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
    Kannan R; Miller S; Singh BN
    Drug Metab Dispos; 1985; 13(6):646-50. PubMed ID: 2867865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(12):1805-10. PubMed ID: 4096733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial disposition of amiodarone in the dog.
    Latini R; Connolly SJ; Kates RE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patients.
    Flanagan RJ; Storey GC; Holt DW; Farmer PB
    J Pharm Pharmacol; 1982 Oct; 34(10):638-43. PubMed ID: 6128385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.